Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 15Unspecified Adult Solid Tumor, Protocol Specific 3Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Precancerous Conditions 2Pancreatic Neoplasms 2Neoplasms 2Hypocalcemia 2Vitamin D Deficiency 1Tuberous Sclerosis 1Tobacco Use Disorder 1Thyroiditis 1Thyroid Nodule 1Thyroid Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pneumonia 1Pinealoma 1Osteoporosis 1Oligodendroglioma 1Obesity 1Neuroectodermal Tumors, Primitive 1Neoplasm Metastasis 1Mouth Neoplasms 1Meningioma 1Melanoma 1Medulloblastoma 1Leukemia 1Hyperthyroidism 1Hyperplasia 1

Interventions

Gemcitabine 112Cisplatin 76Oxaliplatin 44pembrolizumab 34Fluorouracil 32Capecitabine 30durvalumab 27Leucovorin 26lenvatinib 23Magnetic Resonance Spectroscopy 15Irinotecan 14Nivolumab 12Biopsy 12Albumin-Bound Paclitaxel 12tislelizumab 11Specimen Handling 11Radiofrequency Ablation 11Drug Therapy 11pemigatinib 10apatinib 10Taxes 10Floxuridine 10130-nm albumin-bound paclitaxel 10Radiotherapy 9Bevacizumab 9Platinum 8Folfox protocol 8Carboplatin 81,2-diaminocyclohexaneplatinum II citrate 8tremelimumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Cholangiocarcinoma × Calcitriol × Clear all
NCT01039181 2009-12-24

Calcitriol in Advanced Intrahepatic Cholangiocarcinoma

National Science and Technology Development Agency, Thailand

Phase 2 Unknown
28 enrolled
Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡